Research News and Research

RSS

Alzheimer's disease: Gene expression level influences promotion of disorder or protection against development

Using sophisticated techniques that scan the genomes of patients, researchers at the Mayo Clinic campus in Florida have found that a gene appears to either help protect against development of Alzheimer's disease, or promote the disorder depending on the level of gene in the brain.

18 Mar 2010

Enzo Biochem announces supply and distribution agreement between Enzo Life Sciences and Cancer Genetics

Enzo Biochem, Inc., a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, announced today a supply and distribution agreement between Enzo Life Sciences and privately-owned Cancer Genetics Inc., a leading producer of nucleic acid products used in genomic research.

18 Mar 2010

Agendia to participate in groundbreaking clinical trial for breast cancer

Agendia, a world leader in molecular cancer diagnostics, announced today it will participate in the highly anticipated I-SPY 2 TRIAL for breast cancer, set to launch at the first of nearly twenty research sites.

18 Mar 2010

Democrats take aim at deficit targets, continue to wait for CBO numbers on health overhaul

"With Congress just days away from an expected vote, Democrats still hadn't settled on final language of the bill and until they do the Congressional Budget Office can't release an estimate for how much the complete package would cost." House Majority Leader Steny Hoyer (D., Md.) said yesterday that "he hoped Democratic leaders would be able to lock down final details soon.

18 Mar 2010

New findings promise to have fundamental significance in the fight against cancer

Cells have two different protection programs to safeguard them from getting out of control under stress and from dividing without stopping and developing cancer. Until now, researchers assumed that these protective systems were prompted separately from each other.

18 Mar 2010

Dems newly-favored tactic to advance health measure draws GOP rage

The latest strategy House Democratic leaders have considered for passing the health overhaul bill would allow lawmakers to approve a Senate-passed version of the bill without a direct vote, The Washington Post reports. Instead, a so-called "self-executing rule would say that the Senate's version of health-care legislation would be deemed approved if House members adopt a set of changes to that bill."

18 Mar 2010

I-SPY 2: The Biomarkers Consortium launches clinical trial for high risk, fast-growing breast cancers

The Biomarkers Consortium, a unique public-private partnership that includes the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH), and major pharmaceutical companies, led by the Foundation for the National Institutes of Health (FNIH), today announced the launch of a highly anticipated clinical trial to help screen promising new drugs being developed for women with high risk, fast-growing breast cancers—women for whom an improvement over standard treatment could dramatically change the odds of survival.

18 Mar 2010

As Medicare pay shrinks, some California doctors hike patient fees

Kaiser Health News staff writer Christopher Weaver writes about a California cardiology group that has confronted steep Medicare cuts with a tactic that may irk patients who already face soaring health costs.

18 Mar 2010

Obama to appear on Fox News; Heath reform will be high on his topic list

New York Times: President Obama is scheduled to give an interview with Bret Baier of Fox News Wednesday evening. The interview comes "at the height of a week in which Democrats, including Mr. Obama, are pressing allies and lawmakers to push ahead to get the health care bill passed in the House despite solid Republican opposition and the lessening of public support for the legislation." The interview comes after Obama administration aides last year criticized Fox News for its political coverage and commentary (3/16).

17 Mar 2010

Cut looms for Medicare payments to doctors

Marketwatch/The Seattle Times reports on the looming 21 percent cut to physicians' Medicare payments. "The cut was to take effect March 1 until Congress delayed it by 30 days. The Senate then voted last Wednesday to postpone the cut an additional six months as part of a larger bill that extends unemployment benefits. The measure now moves to the House."

17 Mar 2010

AstraZeneca's CRESTOR: Health Canada approves new indication

AstraZeneca announced today that Health Canada has approved CRESTOR (rosuvastatin calcium) to reduce the risk of nonfatal myocardial infarction (heart attack), nonfatal stroke, and coronary artery revascularization in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease.

17 Mar 2010

Prevenar 13: Immunogenic and well tolerated in young children previously vaccinated with Prevenar

According to results from a Phase III safety and immunogenicity study presented today, Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine, [13-valent, adsorbed]) was shown to be immunogenic and generally well tolerated in healthy young children who had received at least three prior doses of Prevenar (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed). These data were presented today at the 7th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) in Tel Aviv, Israel.

17 Mar 2010

Hospitals can save more than $1M annually by implementing Masimo Patient SafetyNet with SET pulse oximetry

Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new cost-effectiveness study shows that implementation of the Masimo Patient SafetyNet remote monitoring and clinician notification system with Masimo SET pulse oximetry saved one hospital $817,000 in its first year.

17 Mar 2010

CDISC approves Nextrials as one of 15 registered solutions providers

Nextrials, Inc., a leader in clinical research software and services, has been approved by the Clinical Data Interchange Standards Consortium as one of 15 registered solutions providers, and is the only company offering an electronic data capture (EDC) product supporting the CDISC Healthcare Link Initiative.

17 Mar 2010

CNS Network purchases Logos Technologies' pro-active EDC system for streamlining clinical trials

It is announced today that CNS Network has purchased ALPHADAS®, Logos Technologies Inc’s early phase, e-source data capture system and site automation tools to accelerate and streamline its clinical trials. ALPHADAS is to be implemented in their Orange County Research Center, California, USA.

17 Mar 2010

ALS TDI, Aestus Therapeutics to test potential small-molecule compounds to stop progression of ALS

The ALS Therapy Development Institute and Aestus Therapeutics, Inc., announced their plans today to test several potential small-molecule compounds to slow or stop the progression of Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig's disease).

17 Mar 2010

Somanetics first-quarter 2010 net revenues up 18%

Somanetics Corporation reported net revenues of $13.1 million for the first quarter ended February 28, 2010, an 18 percent increase from $11.2 million in the same period of 2009.

17 Mar 2010

Public health experts review planning outreach to populations vulnerable to HIV infection and STBBI

Public health experts from across Canada will meet in Toronto March 11 and 12 to review and discuss planning outreach to populations vulnerable to HIV infection and sexually transmitted and blood borne infections (STBBI). The meeting will be hosted by Winnipeg's National Collaborating Centre for Infectious Diseases.

17 Mar 2010

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010. This action is being taken as a result of weaker than expected operating results for the second quarter ending March 31, 2010, based on preliminary results to date. Separately, Meridian announced that it will file a 510(k) for FDA marketing clearance next week in connection with its illumigene™ C. difficile product.

17 Mar 2010

SBRT may improve survival rates for lung-cancer patients: Study

A radiation therapy that uses multiple radiation beams to target tumors precisely has been shown to eliminate the primary tumor and ultimately may improve survival rates for lung-cancer patients unable to undergo surgery, according to UT Southwestern Medical Center physicians who led a national clinical trial of the treatment.

17 Mar 2010

Research News and Research

Alzheimer's disease: Gene expression level influences promotion of disorder or protection against development

Enzo Biochem announces supply and distribution agreement between Enzo Life Sciences and Cancer Genetics

Agendia to participate in groundbreaking clinical trial for breast cancer

Democrats take aim at deficit targets, continue to wait for CBO numbers on health overhaul

New findings promise to have fundamental significance in the fight against cancer

Dems newly-favored tactic to advance health measure draws GOP rage

I-SPY 2: The Biomarkers Consortium launches clinical trial for high risk, fast-growing breast cancers

As Medicare pay shrinks, some California doctors hike patient fees

Obama to appear on Fox News; Heath reform will be high on his topic list

Cut looms for Medicare payments to doctors

AstraZeneca's CRESTOR: Health Canada approves new indication

Prevenar 13: Immunogenic and well tolerated in young children previously vaccinated with Prevenar

Hospitals can save more than $1M annually by implementing Masimo Patient SafetyNet with SET pulse oximetry

CDISC approves Nextrials as one of 15 registered solutions providers

CNS Network purchases Logos Technologies' pro-active EDC system for streamlining clinical trials

ALS TDI, Aestus Therapeutics to test potential small-molecule compounds to stop progression of ALS

Somanetics first-quarter 2010 net revenues up 18%

Public health experts review planning outreach to populations vulnerable to HIV infection and STBBI

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

SBRT may improve survival rates for lung-cancer patients: Study

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence